Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
International Journal of Health Care Quality Assurance Incorporating Leadership in Health Services|June 25, 2005
Sampling for quality assurance of grading decisions in diabetic retinopathy screening: designing the system to detect errorsJim SlatteryGastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates|May 2, 2002
Biliary and pancreatic stentsJim SlatteryPharmacoepidemiology and Drug Safety|April 18, 2020
Assessing strength of evidence for regulatory decision making in licensing: What proof do we need for observational studies of effectiveness?Jim Slattery, Xavier KurzDrug Safety|June 12, 2013
Choosing thresholds for statistical signal detection with the proportional reporting ratioJim Slattery, Yolanda Alvarez, Ana HidalgoDrug Safety|May 22, 2010
Validation of statistical signal detection procedures in eudravigilance post-authorization data: a retrospective evaluation of the potential for earlier signallingYolanda Alvarez, Ana Hidalgo, Francois Maignen, et al.Drug Safety|May 23, 2018
Cohort Study of Psychiatric Adverse Events Following Exposure to Levonorgestrel-Containing Intrauterine Devices in UK General PracticeJim Slattery, Daniel Morales, Luis Pinheiro, et al.BMC Medicine|January 16, 2018
Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerationsDaniel R Morales, Jim Slattery, Stephen Evans, et al.British Journal of Clinical Pharmacology|February 19, 2020
Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: A series of population-based nested case-control studiesDaniel R Morales, Alexandra Pacurariu, Jim Slattery, et al.Drug Safety|April 28, 2005
Incidence of thrombotic cardiovascular events in patients taking celecoxib compared with those taking rofecoxib: interim results from the New Zealand Intensive Medicines Monitoring ProgrammeMira Harrison-Woolrych, Peter Herbison, Rachael McLean, et al.Pharmacoepidemiology and Drug Safety|November 17, 2017
An algorithm to detect unexpected increases in frequency of reports of adverse events in EudraVigilanceLuis C Pinheiro, Gianmario Candore, Cosimo Zaccaria, et al.Pageof 4